In the present study, we reported a series of designed molecules that integrated quinoline core and sulfonyl moiety, with the objective of evaluating the substituent and linker effects on anticancer activities in HCC cells and the associated putative mechanistic target, the transcription factor NF-κB, with bioinformatic, and molecular analysis. Here, NFKB1 is linked to hepatocellular carcinoma.